| 000 | 00938 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513221317.0 | ||
| 264 | 0 | _c20001102 | |
| 008 | 200011s 0 0 eng d | ||
| 022 | _a0165-2478 | ||
| 024 | 7 |
_a10.1016/s0165-2478(00)00242-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTartour, E | |
| 245 | 0 | 0 |
_aCancer vaccines 2000. _h[electronic resource] |
| 260 |
_bImmunology letters _cSep 2000 |
||
| 300 |
_a1-3 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCancer Vaccines _ximmunology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy, Active |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 700 | 1 | _aFridman, W H | |
| 773 | 0 |
_tImmunology letters _gvol. 74 _gno. 1 _gp. 1-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-2478(00)00242-x _zAvailable from publisher's website |
| 999 |
_c10942902 _d10942902 |
||